Synapse

← Charles M. Perou

Papers by Charles M. Perou

Page 5 · newest first

  1. The molecular portraits of breast tumors are conserved across microarray platforms2019
  2. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors2019
  3. Deep Multi-View Learning via Task-Optimal CCA2019
  4. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitorDisease Models & Mechanisms · 2019
  5. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer seriesBMC Genomics · 2019
  6. The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative ChemotherapyClinical Cancer Research · 2019
  7. MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppressionNature Communications · 2019
  8. Separation of breast cancer and organ microenvironment transcriptomes in metastasesBreast Cancer Research · 2019
  9. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursBreast Cancer Research · 2019
  10. Improved indel detection in DNA and RNA via realignment with ABRA2Bioinformatics · 2019
  11. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancerProceedings of the National Academy of Sciences · 2018
  12. A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancerBreast Cancer Research and Treatment · 2018
  13. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancerGenome Medicine · 2018
  14. Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastCell Reports · 2018
  15. Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtypenpj Breast Cancer · 2018
  16. Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland DevelopmentCell Reports · 2018
  17. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerCell Reports · 2018
  18. Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelClinical Cancer Research · 2018
  19. Tumor mutational burden is a determinant of immune-mediated survival in breast cancerOncoImmunology · 2018
  20. Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerClinical Cancer Research · 2018
  21. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinomaScience · 2018
  22. Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assayBreast Cancer Research · 2018
  23. TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer casesnpj Breast Cancer · 2018
  24. Integrated Molecular Characterization of Testicular Germ Cell TumorsCell Reports · 2018
  25. FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationCancer Research · 2018
  26. Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancerCancer Treatment Reviews · 2018
  27. PAM50 and Risk of Recurrence Scores for Interval Breast CancersCancer Prevention Research · 2018
  28. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional networkNature Communications · 2018
  29. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerJournal of Clinical Investigation · 2018
  30. The association between copy number aberration, DNA methylation and gene expression in tumor samplesNucleic Acids Research · 2018
  31. Frequency of breast cancer subtypes among African American women in the AMBER consortiumBreast Cancer Research · 2018
  32. Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined ClassificationClinical Cancer Research · 2018
  33. Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer StudyBreast Cancer Research · 2017
  34. Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy – results from two independent randomized trialsActa Oncologica · 2017
  35. A class of GATA3 mutation reprograms the breast cancer transcriptional network through gain and loss of function2017
  36. Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsClinical Cancer Research · 2017
  37. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancerJournal of Clinical Investigation · 2017
  38. Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculenpj Precision Oncology · 2017
  39. Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancernpj Breast Cancer · 2017
  40. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progressionOncogene · 2017
  41. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer StudyJNCI Journal of the National Cancer Institute · 2017
  42. Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancerScience Translational Medicine · 2017
  43. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasJAMA Oncology · 2017
  44. SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profilingGenome biology · 2017
  45. A murine preclinical syngeneic transplantation model for breast cancer precision medicineScience Advances · 2017
  46. Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsNature Communications · 2017
  47. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cellsnpj Breast Cancer · 2017
  48. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune LandscapeJournal of Thoracic Oncology · 2017
  49. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast CancerCancer Research · 2017
  50. Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancersScience Signaling · 2017